Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Chimeric Therapeutics Ltd C.CHM


Primary Symbol: CHMMF

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase 1B clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of NK and CAR NK assets with plans for Phase 1B clinical trials in solid tumors and blood cancers.


OTCPK:CHMMF - Post by User

Post by fredskion Nov 07, 2018 3:29pm
163 Views
Post# 28939360

Cannabis stocks surge as U.S. midterm elections

Cannabis stocks surge as U.S. midterm electionshttps://www.marketwatch.com/story/cannabis-stocks-surge-again-after-michigan-votes-to-legalize-recreational-pot-2018-11-07


Cannabis stocks surge as U.S. midterm elections, Jeff Sessions resignation bolster hopes for a green wave

Published: Nov 7, 2018 3:24 p.m. ET

Marijuana sector heads for 7th straight gain, as Jeff Session’s resignation and House’s flip to Democrats drive optimism for U.S. companies

User image

Shares of cannabis companies traded broadly higher Wednesday, as U.S. midterm elections are likely to usher in a green wave, with Michigan voting to legalize recreational pot and other states supporting medical marijuana likely just the beginning.

The sector got a further boost after long-time cannabis opponent Attorney General Jeff Sessions resigned “at the request” of President Trump.

The ETFMG Alternative Harvest exchange-traded fund MJ, +7.15% shot up 6.2% in late-afternoon, with 33 of 37 components trading higher, putting it on track for a seventh straight gain. The sector tracker has now run up 25% during its win streak.

The Horizons Marijuana Life Sciences ETF HMMJ, +6.82% ran up 5.3%, also headed for a seven-day win streak.

Among the most-active stocks, Aurora Cannabis Inc. ACB, +9.27% hiked up 6.4%, Canopy Growth Corp. CGC, +7.11% tacked on 6.0%, Cronos Group Inc.CRON, +8.29% surged 8.4% and Tilray Inc. TLRY, +30.18% soared 31%.

Jeff Sessions resignation, coupled with a Democrat-controlled House of Representatives, could prove a boon for the pot industry in the U.S. It was Sessions who rescinded an Obama-era policy used as protection for states that have legalized marijuana.....






<< Previous
Bullboard Posts
Next >>